SI-BONE Sets Date for Fourth-Quarter 2024 Financial Results
SI-BONE Announces Upcoming Financial Report Date
SI-BONE, Inc. (Nasdaq: SIBN), based in Santa Clara, California, is preparing to unveil its financial results for the fourth quarter and full year end. This eagerly awaited announcement will take place after the market closes, promising to provide insights into the company's performance and future directions.
Key Details of the Financial Report
As the date approaches, SI-BONE has confirmed that its management team will host a conference call on the day of the report. Investors are invited to join this important discussion, which will begin at 1:30 p.m. Pacific Time and 4:30 p.m. Eastern Time.
How to Access the Conference Call
For those interested in participating, registration is necessary. Specific details regarding the registration process have been shared to facilitate access for all interested parties. Furthermore, the company will provide a live audio broadcast of the entire event, allowing investors and stakeholders to gain real-time insights into the company's financial health.
Understanding SI-BONE, Inc.
SI-BONE has established itself as a pioneer in the development of innovative solutions for sacropelvic disorders. Since launching its unique technologies and services, the company has supported a vast number of healthcare professionals, helping to facilitate critical surgical procedures. In fact, over 4,300 physicians have utilized SI-BONE's techniques, contributing to more than 115,000 successfully performed procedures since 2009.
Impactful Clinical Evidence
The efficacy and safety of SI-BONE's technologies are backed by a robust body of clinical evidence. Two randomized controlled trials, along with over 160 peer-reviewed publications, highlight the positive outcomes associated with the use of their innovations. This extensive research not only bolsters the credibility of SI-BONE's offerings but also improves the reassurance of patients and healthcare providers alike.
Expanding Beyond Sacropelvic Disorders
While SI-BONE is well-recognized for its advancements in minimally invasive surgical techniques for sacropelvic disorders, the company is not resting on its laurels. It has adeptly expanded its market reach, introducing solutions for adjacent medical areas, including adult deformity correction, sacropelvic fixation techniques, and pelvic trauma solutions. This proactive approach has positioned SI-BONE as a leader in the medical device industry.
Continued Commitment to Innovation
As the medical needs of patients evolve, so too does SI-BONE. The company is committed to advancing its array of products and services, which include the well-regarded iFuse line. Each of these innovations reflects SI-BONE's dedication to improving patient outcomes through cutting-edge medical technology.
Looking Forward at SI-BONE
Beyond the upcoming financial report, SI-BONE will continue to focus on growth and expansion within the healthcare landscape. As they cultivate research and development initiatives, their overarching goal remains the same: to enhance the lives of patients suffering from sacropelvic disorders while leading in surgical innovation.
Investor Relations Contact Information
For additional inquiries, potential investors or interested parties can reach out directly to Saqib Iqbal via email. Engaging with the company's investor relations team is encouraged, ensuring stakeholders have access to accurate and timely information.
Frequently Asked Questions
What financial results is SI-BONE expected to announce?
SI-BONE will report its fourth-quarter and full-year financial results, detailing its performance and future outlook.
When is the conference call scheduled?
The conference call will take place on February 24, at 1:30 p.m. Pacific Time.
How can I access the live conference call?
Investors can register to participate in the call, which will also be available for listening on the company's website.
What is SI-BONE known for?
SI-BONE is known for its innovative technologies related to surgical treatments of sacropelvic disorders, with a history of significant clinical success.
Who can I contact for investor relations?
For investor inquiries, you can contact Saqib Iqbal for assistance and information related to SI-BONE's operations.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.